PRSS35 and liver cancer: Western blot (WB) analysis using an antibody that recognizes the N-terminus of PRSS35 indicated that both intracellular and extracellular PRSS35 protein levels were markedly reduced in PLC, HepG2, and Hep3B liver cancer cells, relative to its accumulation in THLE3 cells (Fig. 1b).